FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2564603710> ?p ?o ?g. }

• W2564603710 endingPage "669.e1" @default.
• W2564603710 startingPage "662" @default.
• W2564603710 abstract "Drug survival is defined as the time period of treatment with a certain drug until its cessation. The role of previous exposure to traditional systemic treatments in biologic survival is still unknown.To investigate the drug survival rates of biologic treatments in patients with psoriasis and to identify predictor factors.Survival analysis was performed on patients with severe psoriasis who received adalimumab, infliximab, etanercept, and ustekinumab for treatment of psoriasis, drawn from the Clalit Health Services database. Multivariate analysis was performed adjusting for demographic variables; metabolic syndrome and its components; psoriatic arthritis; biologic naivety; coadministration of methotrexate, acitretin, or cyclosporine; and previous standard systemic treatment exposure.Among 907 patients treated with 1575 biologic treatments, ustekinumab had a significantly higher survival rate than tumor necrosis factor inhibitors. Biologic naivety and concomitant methotrexate intake were positive predictors for drug survival, whereas the female sex and the duration of previous systemic treatments were negative predictors.Data regarding disease severity or duration could not be drawn from the Clalit Health Services database.Ustekinumab had better retention rates in comparison with other investigated biologics in patients with severe psoriasis, most of whom used it as a third line therapy." @default.
• W2564603710 created "2017-01-06" @default.
• W2564603710 creator A5008417497 @default.
• W2564603710 creator A5025316260 @default.
• W2564603710 creator A5035349151 @default.
• W2564603710 creator A5035796849 @default.
• W2564603710 creator A5058782928 @default.
• W2564603710 creator A5060867806 @default.
• W2564603710 creator A5067537333 @default.
• W2564603710 creator A5074973012 @default.
• W2564603710 creator A5085948909 @default.
• W2564603710 creator A5086784791 @default.
• W2564603710 date "2017-04-01" @default.
• W2564603710 modified "2023-09-24" @default.
• W2564603710 title "Biologic drug survival in Israeli psoriasis patients" @default.
• W2564603710 cites W1597607780 @default.
• W2564603710 cites W1692288477 @default.
• W2564603710 cites W1973064602 @default.
• W2564603710 cites W1975091847 @default.
• W2564603710 cites W2033978760 @default.
• W2564603710 cites W2033988686 @default.
• W2564603710 cites W2041791353 @default.
• W2564603710 cites W2047252573 @default.
• W2564603710 cites W2057221812 @default.
• W2564603710 cites W2073196059 @default.
• W2564603710 cites W2073213739 @default.
• W2564603710 cites W2073797451 @default.
• W2564603710 cites W2134348930 @default.
• W2564603710 cites W2145492843 @default.
• W2564603710 cites W2155441883 @default.
• W2564603710 cites W2257545295 @default.
• W2564603710 cites W2297486162 @default.
• W2564603710 cites W2298475738 @default.
• W2564603710 cites W2299859542 @default.
• W2564603710 cites W2317900027 @default.
• W2564603710 cites W2407885123 @default.
• W2564603710 cites W338292988 @default.
• W2564603710 cites W588735104 @default.
• W2564603710 doi "https://doi.org/10.1016/j.jaad.2016.10.033" @default.
• W2564603710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28038888" @default.
• W2564603710 hasPublicationYear "2017" @default.
• W2564603710 type Work @default.
• W2564603710 sameAs 2564603710 @default.
• W2564603710 citedByCount "51" @default.
• W2564603710 countsByYear W25646037102017 @default.
• W2564603710 countsByYear W25646037102018 @default.
• W2564603710 countsByYear W25646037102019 @default.
• W2564603710 countsByYear W25646037102020 @default.
• W2564603710 countsByYear W25646037102021 @default.
• W2564603710 countsByYear W25646037102022 @default.
• W2564603710 countsByYear W25646037102023 @default.
• W2564603710 crossrefType "journal-article" @default.
• W2564603710 hasAuthorship W2564603710A5008417497 @default.
• W2564603710 hasAuthorship W2564603710A5025316260 @default.
• W2564603710 hasAuthorship W2564603710A5035349151 @default.
• W2564603710 hasAuthorship W2564603710A5035796849 @default.
• W2564603710 hasAuthorship W2564603710A5058782928 @default.
• W2564603710 hasAuthorship W2564603710A5060867806 @default.
• W2564603710 hasAuthorship W2564603710A5067537333 @default.
• W2564603710 hasAuthorship W2564603710A5074973012 @default.
• W2564603710 hasAuthorship W2564603710A5085948909 @default.
• W2564603710 hasAuthorship W2564603710A5086784791 @default.
• W2564603710 hasConcept C126322002 @default.
• W2564603710 hasConcept C16005928 @default.
• W2564603710 hasConcept C2776260265 @default.
• W2564603710 hasConcept C2777011040 @default.
• W2564603710 hasConcept C2777138892 @default.
• W2564603710 hasConcept C2777226972 @default.
• W2564603710 hasConcept C2777575956 @default.
• W2564603710 hasConcept C2778496887 @default.
• W2564603710 hasConcept C2778975655 @default.
• W2564603710 hasConcept C2779134260 @default.
• W2564603710 hasConcept C2779384505 @default.
• W2564603710 hasConcept C2780035454 @default.
• W2564603710 hasConcept C2780132546 @default.
• W2564603710 hasConcept C2780564577 @default.
• W2564603710 hasConcept C2781059491 @default.
• W2564603710 hasConcept C50382708 @default.
• W2564603710 hasConcept C71924100 @default.
• W2564603710 hasConcept C98274493 @default.
• W2564603710 hasConceptScore W2564603710C126322002 @default.
• W2564603710 hasConceptScore W2564603710C16005928 @default.
• W2564603710 hasConceptScore W2564603710C2776260265 @default.
• W2564603710 hasConceptScore W2564603710C2777011040 @default.
• W2564603710 hasConceptScore W2564603710C2777138892 @default.
• W2564603710 hasConceptScore W2564603710C2777226972 @default.
• W2564603710 hasConceptScore W2564603710C2777575956 @default.
• W2564603710 hasConceptScore W2564603710C2778496887 @default.
• W2564603710 hasConceptScore W2564603710C2778975655 @default.
• W2564603710 hasConceptScore W2564603710C2779134260 @default.
• W2564603710 hasConceptScore W2564603710C2779384505 @default.
• W2564603710 hasConceptScore W2564603710C2780035454 @default.
• W2564603710 hasConceptScore W2564603710C2780132546 @default.
• W2564603710 hasConceptScore W2564603710C2780564577 @default.
• W2564603710 hasConceptScore W2564603710C2781059491 @default.
• W2564603710 hasConceptScore W2564603710C50382708 @default.
• W2564603710 hasConceptScore W2564603710C71924100 @default.
• W2564603710 hasConceptScore W2564603710C98274493 @default.

• next